Breakthrough   E xophiala dermatitidis  infection during prophylactic administration of micafungin during second umbilical cord blood transplantation after graft failure | Zendy

Watanabe Naoki | Zendy; Gotoh Akihiko | Zendy; Shirane Shuichi | Zendy; Hamano Yasuharu | Zendy; Hirai Yuji | Zendy; Shimizu Maika | Zendy; Nakamura Ayako | Zendy; Matsumoto Kana | Zendy; Morita Kunihiko | Zendy; Mori Takeshi | Zendy; Ohsaka Akimichi | Zendy; Komatsu Norio | Zendy

Premium

Breakthrough E xophiala dermatitidis infection during prophylactic administration of micafungin during second umbilical cord blood transplantation after graft failure

Author(s) -

Watanabe Naoki,

Gotoh Akihiko,

Shirane Shuichi,

Hamano Yasuharu,

Hirai Yuji,

Shimizu Maika,

Nakamura Ayako,

Matsumoto Kana,

Morita Kunihiko,

Mori Takeshi,

Ohsaka Akimichi,

Komatsu Norio

Publication year - 2018

Publication title -

transplant infectious disease

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.69

H-Index - 67

eISSN - 1399-3062

pISSN - 1398-2273

DOI - 10.1111/tid.12833

Subject(s) - micafungin , medicine , umbilical cord , umbilical cord blood transplantation , transplantation , blood stream , surgery , hematopoietic stem cell transplantation , antifungal , voriconazole , immunology , dermatology

E xophiala dermatitidis infections in patients with hematological malignancies are very rare. Our patient had a blood stream infection caused by E . dermatitidis following the second umbilical cord blood transplantation ( UCBT ) after graft failure during the first UCBT . To our knowledge, this is the first report describing a breakthrough fungal infection caused by E . dermatitidis during the prophylactic administration of micafungin ( MCFG ). Therefore, MCFG ‐treated patients should be monitored for breakthrough E . dermatitidis infection during hematopoietic stem cell transplantation.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research